QUICK LINKS:

EFS

Gene-to-Protein & Gene-to-Structure

Viva Engine for Lead Discovery

Membrane Protein Targeted Discovery Technology

请拖入内容到容器

EFS

Viva BioInnovator as the core division of EFS...

Gene-to-Protein & Gene-to-Structure

Viva Biotech is the world's top CRO specialized in ...

Viva Engine for Lead Discovery

A unique platform for drug lead discovery from target to drug candidates consisting of:
请拖入内容到容器

Antibody

Viva is devoted to pushing the boundary of GPCR protein studies. Working closely with experienced experts from GPCR field, well trained researchers in Viva Biotech are able to deliver top quality Cry
View details

Cell Lines

GPCR cell lines developed in-house are ready for distribution and assay screening services.
View details

Crystal Structures

Crystal structures developed in-house are ready for distribution, which can be used for compound soaking.
View details
请拖入内容到容器
Viva Biotech was invited to attend the 40th Annual J.P. Morgan Health Care Conference, 2022
Dr. Han Dai Viva Biotech's world-leading one-stop drug R&D and production services and future strategies, and Highlighted the development and strategies of EFS investment and Incubation services.
Viva Biotech Upcoming Conferences & Events
In the near future, Viva Biotech will attend 8 industry conferences/events.
ABM Therapeutics Completes $30 Million Series B Financing
The funds will be used to accelerate the clinical research of ABM-1310 in China and the U.S., develop several existing preclinical projects, and build the company's pipeline and the management team.
请拖入内容到容器